Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the pharmacokinetic profile of nicotine following a single oral administration of three new nicotine lozenge formulations (V0474) in comparison with two reference products. The clinical and biological safety of V0474 and the lozenge acceptability will also be assessed.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01574898
Study type Interventional
Source Pierre Fabre Medicament
Contact
Status Completed
Phase Phase 1
Start date March 2012
Completion date June 2012

See also
  Status Clinical Trial Phase
Withdrawn NCT00159302 - Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
Completed NCT03728530 - Effect Of Deep Breathing Exercises In Smokers N/A
Completed NCT02089308 - Nicotine Patch - Bioequivalence Study Phase 1
Completed NCT01658215 - Nicotine Patch - Multidose Bioequivalence Study Phase 1
Completed NCT01658202 - Nicotine Patch Bioequivalence Study Phase 1
Terminated NCT00753870 - Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers Phase 1
Completed NCT01164072 - Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) N/A
Completed NCT01194583 - Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges N/A
Completed NCT01188239 - A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) N/A